3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Breast Neoplasms
2439
Neoplasms
1845
Carcinoma, Non-Small-Cell Lung
1615
Prostatic Neoplasms
1315
Colorectal Neoplasms
1149
Lung Neoplasms
993
Neoplasm Metastasis
838
Multiple Myeloma
802
Leukemia, Myeloid, Acute
778
Ovarian Neoplasms
686
Pancreatic Neoplasms
673
Melanoma
669
Squamous Cell Carcinoma of Head and Neck
592
Carcinoma, Hepatocellular
571
Recurrence
570
Brain Neoplasms
531
Glioblastoma
521
Stomach Neoplasms
506
Head and Neck Neoplasms
504
Triple Negative Breast Neoplasms
474
Lymphoma
463
Uterine Cervical Neoplasms
457
Carcinoma, Renal Cell
430
Precursor Cell Lymphoblastic Leukemia-Lymphoma
421
Lymphoma, Non-Hodgkin
392
Endometrial Neoplasms
386
Sarcoma
372
Lymphoma, Follicular
358
Urinary Bladder Neoplasms
356
Lymphoma, Large B-Cell, Diffuse
356
Interventions
posaconazole
1
Fluconazole
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Aspergillosis
×
1 year
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled